Shandong Sanyuan Biotechnology Co.,Ltd. (SHE:301206)

SHE:301206 Income Statement

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Mar 31, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Dec 31, 2020
Operating Revenue	656.82	698.51	482.71	655.82	1,641	772.64
Other Revenue	14.4	14.4	16.79	19.09	33.93	10.55
Revenue	671.21	712.9	499.5	674.91	1,675	783.18
Revenue Growth (YoY)	16.71%	42.72%	-25.99%	-59.71%	113.91%	64.27%
Cost of Revenue	584.03	635.4	485.47	586.98	973.9	454.01
Gross Profit	87.19	77.51	14.03	87.92	701.42	329.17
Selling, General & Admin	27.74	25.05	20.05	20.3	18.8	13.96
Research & Development	35.14	41.23	50.66	34.08	59	30.34
Other Operating Expenses	3	2.88	2.54	3.21	7.01	5.03
Operating Expenses	67.4	69.8	73.31	57.34	85.17	49.27
Operating Income	19.79	7.71	-59.28	30.58	616.26	279.9
Interest Expense	-	-	-	-	-0	-
Interest & Investment Income	103.59	111.41	117.1	100.34	3.5	2.51
Currency Exchange Gain (Loss)	7.45	7.45	2.68	42.83	-7.47	-11.35
Other Non Operating Income (Expenses)	-2.07	-0.25	-0.2	-0.27	-0.73	-0.39
EBT Excluding Unusual Items	128.76	126.31	60.31	173.48	611.55	270.68
Gain (Loss) on Sale of Investments	-	-	-2.89	-0.33	0.26	-
Gain (Loss) on Sale of Assets	0	-	-	-	-0.59	-0.35
Asset Writedown	-0.07	-0.07	-	-0.21	-0.01	-2.7
Other Unusual Items	1.98	1.96	1.4	11.02	8.68	2.52
Pretax Income	130.67	128.2	58.82	183.96	619.9	270.14
Income Tax Expense	25.08	23.25	2.84	20.27	84.48	37.57
Net Income	105.62	104.95	55.98	163.69	535.42	232.57
Net Income to Common	105.62	104.95	55.98	163.69	535.42	232.57
Net Income Growth	45.84%	87.47%	-65.80%	-69.43%	130.21%	70.62%
Shares Outstanding (Basic)	203	202	200	200	152	152
Shares Outstanding (Diluted)	203	202	200	200	152	152
Shares Change (YoY)	0.78%	0.95%	0.16%	31.61%	-0.00%	3.86%
EPS (Basic)	0.52	0.52	0.28	0.82	3.53	1.53
EPS (Diluted)	0.52	0.52	0.28	0.82	3.53	1.53
EPS Growth	44.71%	85.71%	-65.85%	-76.77%	130.22%	64.29%
Free Cash Flow	-146.11	-155.41	-65.68	-158.4	207.7	65.6
Free Cash Flow Per Share	-0.72	-0.77	-0.33	-0.79	1.37	0.43
Dividend Per Share	1.400	1.400	0.250	0.700	0.667	0.467
Dividend Growth	460.00%	460.00%	-64.29%	5.00%	42.85%	-
Gross Margin	12.99%	10.87%	2.81%	13.03%	41.87%	42.03%
Operating Margin	2.95%	1.08%	-11.87%	4.53%	36.78%	35.74%
Profit Margin	15.73%	14.72%	11.21%	24.25%	31.96%	29.70%
Free Cash Flow Margin	-21.77%	-21.80%	-13.15%	-23.47%	12.40%	8.38%
EBITDA	87.65	73.92	0.32	69.33	641.9	296.79
EBITDA Margin	13.06%	10.37%	0.07%	10.27%	38.31%	37.90%
D&A For EBITDA	67.86	66.21	59.61	38.75	25.65	16.89
EBIT	19.79	7.71	-59.28	30.58	616.26	279.9
EBIT Margin	2.95%	1.08%	-11.87%	4.53%	36.78%	35.74%
Effective Tax Rate	19.19%	18.14%	4.82%	11.02%	13.63%	13.91%
Revenue as Reported	671.21	712.9	499.5	674.91	1,675	783.18
Advertising Expenses	-	1.26	1.17	0.72	1.08	0.73

Source: S&P Global Market Intelligence. Standard template. Financial Sources.